By Michelle Meyer So, one thing they say about being on the law teaching market is that you likely will never before have enjoyed — and, less happily, will likely never again enjoy — so much attention to your work and so many opportunities to discuss it. That’s totally true, and it’s totally fabulous. But there’s…
By Casey Thomson The flu, gun control, and legal action against the FDA – all amongst our Twitter feeds this past week. Read on for more: Frank Pasquale (@FrankPasquale) retweeted a link to the FDA’s current legal trouble concerning their failure to disclose antibiotic resistance data. The Government Accountability Project (GAP) is accusing the FDA…
By Elizabeth Sepper 2013 is rife with reports of the terrible human costs of the flu. Emergency rooms nationwide have been overwhelmed. Art Caplan’s great blog post urges doctors to educate patients that the flu vaccine is not just for their benefit. He tells healthcare providers to send a clear message by getting the flu…
By Jonathan J. Darrow In a well-researched, recent post, Patrick O’Leary addresses the FDA’s efficacy requirements as applied to an old drug, Acthar (corticotropin), that was first approved in 1952 and granted an orphan designation in 2010 for the treatment of infantile spasms. The initial approval therefore occurred before the Drug Amendments of 1962, which…
By Casey Thomson This week’s round-up looks at the problems of substandard drug prevalence abroad, NIH’s possible push for an anonymous grant-awarding process, and the Liverpool Care Pathway investigation. Check it out below! Dan Vorhaus (@genomicslawyer) included a link to a report on the recent launch of Personal Genome Launch Canada. The post includes links…
By Christopher Robertson On these pages, Michelle Mello recently posted a discussion of her new article with Lindsey Murtagh, Thomas Gallagher, and Penny Andrew, called “Disclosure-And-Resolution Programs That Include Generous Compensation Offers May Prompt A Complex Patient Response.” In this vignette-based online study, the authors put respondents in clinical scenarios with medical errors, and then added…
By Casey Thomson This week’s Twitter Round-Up features an “American Idol-style” selection of research grant winners, the problems facing children in Syria attempting to be vaccinated, and a review of where we stand with current patient health information privacy and security. Michelle Meyer (@MichelleNMeyer) retweeted an article about a newly emerging landmark case in the United…
[Editor’s Note, I am guest posting this on behalf of my wonderful colleague Michelle Mello, at the Harvard School of Public Health] Gridlock in many state legislatures over proposals to reform medical liability by capping noneconomic damages—and growing recognition that caps have only modest success in addressing the problems with the malpractice system—have led health…
by Dan Vorhaus and Phil Ross (cross-posted from Genomics Law Report) For years, and with increasing frequency, health care and information technology companies have touted the potential of mobile medical and health applications and technologies to improve the quality and delivery of health care through the use of technology. While the future of mobile health (frequently…
By Christopher Robertson New hospital safety scores were released this week, and around the country, those that scored well are crowing (see e.g., here and here). The data is provided by a nonprofit called Leapfrog Group, which compiles survey-responses and CMS data on a website called hospitalsafetyscore.org. Check out your own hospitals. The Leapfrog Group…
